MARKETS
Earnings

Aethlon Medical Q1 EPS $(4.02) Misses $(0.79) Estimate; Cash & Equivalents $4.9M

Aug 13, 2026 · 04:17 PM ET· updated 1h ago

Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(4.02) per share which missed the analyst consensus estimate of $(0.79) by 415.38 percent. This is a 90.52 percent increase over losses of $(42.42) per share

Share
Why It Matters

Aethlon Medical lost way more money than experts thought it would this quarter. When a company loses more cash than expected and has only $4.9 million left, it's a sign to watch how long they can keep operating.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.